Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Oncol. 1997 Jun;24(3 Suppl 9):S9-81-S9-93.

Induction of interleukin-1 and interleukin-1 receptor antagonist.

Author information

  • 1Department of Medicine, University of Colorado Health Science Center, Denver 80262, USA.

Abstract

Drugs that affect the production or action, or both, of the pleiotropic inflammatory cytokine interleukin-1 (IL-1) are predicted to have a significant impact on a variety of human diseases. The biochemical properties of IL-1 and the IL-1 receptor antagonist, the mechanism for their production, and the factors that regulate their release are discussed here. The association of IL-1 with various disease states is also reviewed. Various classes of drugs that can be used to manipulate the production of IL-1 and IL- I receptor antagonist are described. Interferon-alpha2b is a potent inhibitor in vitro of the induction of IL-1 and tumor necrosis factor by IL-1 and can induce high circulating levels of the anti-inflammatory soluble tumor necrosis factor receptor and IL-1 receptor antagonist in humans. Thus, interferon-alpha2b exhibits potent anti-inflammatory effects.

PMID:
9208877
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk